LCM
GILD icon

Legato Capital Management’s Gilead Sciences GILD Stock Holding History

Legato Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$588K Sell
4,216
-2,800
-40% -$392K 0.05% 504
2025
Q4 		$861K Buy
+7,016
New +$853K 0.07% 391
2021
Q2 		– Sell
-26,500
Closed -$1.71M – 369
2021
Q1 		$1.71M Hold
26,500
– – 0.32% 95
2020
Q4 		$1.54M Hold
26,500
– – 0.29% 101
2020
Q3 		$1.68M Buy
+26,500
New +$1.84M 0.37% 85

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Legato Capital Management's GILD Position: Q1 2026 in Review

Legato Capital Management reduced its Gilead Sciences (GILD) stake by 40% in Q1 2026, selling an estimated $392K and leaving 4,216 shares worth $588K. The position accounts for 0.05% of the portfolio, ranked #504.

Legato Capital Management first reported a position in GILD in Q3 2020 and has held it in 5 quarters since. The position peaked at $1.71M in Q1 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Legato Capital Management held 4,216 shares of Gilead Sciences worth $588K as of Q1 2026.
  • Legato Capital Management sold 2,800 Gilead Sciences shares in Q1 2026, an estimated $392K.
  • Gilead Sciences made up 0.05% of Legato Capital Management's portfolio in Q1 2026, its #504 holding.
  • Legato Capital Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 5 quarters since.
  • Legato Capital Management's Gilead Sciences position peaked at $1.71M in Q1 2021.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.